Correlation Between Lineage Cell and Scholar Rock

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lineage Cell and Scholar Rock at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lineage Cell and Scholar Rock into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lineage Cell Therapeutics and Scholar Rock Holding, you can compare the effects of market volatilities on Lineage Cell and Scholar Rock and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lineage Cell with a short position of Scholar Rock. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lineage Cell and Scholar Rock.

Diversification Opportunities for Lineage Cell and Scholar Rock

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lineage and Scholar is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and Scholar Rock Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scholar Rock Holding and Lineage Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lineage Cell Therapeutics are associated (or correlated) with Scholar Rock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scholar Rock Holding has no effect on the direction of Lineage Cell i.e., Lineage Cell and Scholar Rock go up and down completely randomly.

Pair Corralation between Lineage Cell and Scholar Rock

Given the investment horizon of 90 days Lineage Cell Therapeutics is expected to under-perform the Scholar Rock. In addition to that, Lineage Cell is 1.25 times more volatile than Scholar Rock Holding. It trades about -0.14 of its total potential returns per unit of risk. Scholar Rock Holding is currently generating about 0.16 per unit of volatility. If you would invest  3,043  in Scholar Rock Holding on August 29, 2024 and sell it today you would earn a total of  663.00  from holding Scholar Rock Holding or generate 21.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Lineage Cell Therapeutics  vs.  Scholar Rock Holding

 Performance 
       Timeline  
Lineage Cell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lineage Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Scholar Rock Holding 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Scholar Rock Holding are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile basic indicators, Scholar Rock disclosed solid returns over the last few months and may actually be approaching a breakup point.

Lineage Cell and Scholar Rock Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lineage Cell and Scholar Rock

The main advantage of trading using opposite Lineage Cell and Scholar Rock positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lineage Cell position performs unexpectedly, Scholar Rock can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scholar Rock will offset losses from the drop in Scholar Rock's long position.
The idea behind Lineage Cell Therapeutics and Scholar Rock Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios